Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

15 Jun 2023 07:00

RNS Number : 7618C
RIT Capital Partners PLC
15 June 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

15 June 2023

31 May 2023 Net Asset Value

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 May 2023 (with debt at fair value) was 2,348p per £1 ordinary share (30 April 2023: 2,367p).

 

May 2023 Highlights

Global equity markets were flat in May, although this concealed wide differences in performance across and within regional indices. For example, the FTSE All-share declined by -4.7%, China's CSI 300 was down -5.6%, and the S&P 500 equal-weighted index was down -3.8%. By contrast, the focus on Artificial Intelligence boosted a select group of mega-cap technology shares, pushing the NASDAQ 100 higher by nearly +7.7%. Economic news was also mixed with survey data indicating further weakness in the manufacturing sector, whilst services proved more robust. 

· The Quoted Equities book saw positive performance from Japan and Value holdings, offset by weakness in China and Quality Defensive holdings.

· In our Private Investments book, as of 31 May, ~76% of our private funds had reported valuations to 31 March, with ~24% held at 31 December valuations. Q1 marks received to date have led to a positive contribution to NAV, mainly driven by gains from holdings in the Digital Transition theme.

· Our Uncorrelated Strategies book was flat as positive contributions from European credit strategies were offset by market neutral strategies and a decline in the gold price.

· Currency movements contributed positively during the month, reflecting our active risk management approach to currency exposure in the portfolio.

· The Board continued to buy back shares during the month, directly benefitting shareholders via the accretive impact to NAV per share. In the month of May, the company repurchased approximately 1.0 million shares on behalf of shareholders.

· We continue to hold a substantial liquidity balance in the portfolio. As at 31 May, total cash and short-term gilts were approximately £369 million.

 

About RIT Capital Partners plc

RIT Capital Partners plc is an investment company listed on the London Stock Exchange. The Company's investment manager is J. Rothschild Capital Management Limited (JRCM), led by its Executive Committee: CEO Francesco Goedhuis, CIO Ron Tabbouche, CFOO Andrew Jones and CSO Aron Balas. JRCM is authorised and regulated by the FCA.

Website: www.ritcap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFFXQLFBBB
Date   Source Headline
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.